Literature DB >> 7580429

Angiotensin converting enzyme genotypes and disease.

K K Teo.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7580429      PMCID： PMC2550782          DOI： 10.1136/bmj.311.7008.763

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.

Authors:  M V Raynolds; M R Bristow; E W Bush; W T Abraham; B D Lowes; L S Zisman; C S Taft; M B Perryman
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

2.  Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.

Authors:  A J Marian; Q T Yu; R Workman; G Greve; R Roberts
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

3.  Leukaemia incidence after iodine-131 exposure.

Authors:  P Hall; J D Boice; G Berg; G Bjelkengren; U B Ericsson; A Hallquist; M Lidberg; G Lundell; A Mattsson; J Tennvall
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

4.  Linkage of the angiotensinogen gene to essential hypertension.

Authors:  M Caulfield; P Lavender; M Farrall; P Munroe; M Lawson; P Turner; A J Clark
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

5.  Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus.

Authors:  J Ruiz; H Blanché; N Cohen; G Velho; F Cambien; D Cohen; P Passa; P Froguel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction.

Authors:  L Tiret; F Kee; O Poirier; V Nicaud; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; P Amouyel
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

7.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

8.  Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction.

Authors:  M Bøhn; K E Berge; A Bakken; J Erikssen; K Berg
Journal:  Clin Genet       Date:  1993-12       Impact factor: 4.438

9.  Angiotensinogen as a risk factor for essential hypertension in Japan.

Authors:  A Hata; C Namikawa; M Sasaki; K Sato; T Nakamura; K Tamura; J M Lalouel
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease.

Authors:  T Katsuya; G Koike; T W Yee; N Sharpe; R Jackson; R Norton; M Horiuchi; R E Pratt; V J Dzau; S MacMahon
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.